Bifogade filer
Induct - Interim Report Q1 2025
Kurs
+6,82%
Kurs
+6,82%
Open
3,70
High
3,94
Low
3,50
Close
3,76
Kursutveckling under dagen för detta pressmeddelande
(NOK).
Kalender
| Est. tid* | ||
| 2026-06-12 | N/A | Årsstämma |
| 2026-02-12 | 08:40 | Bokslutskommuniké 2025 |
| 2025-11-13 | 08:30 | Kvartalsrapport 2025-Q3 |
| 2025-08-14 | 08:30 | Kvartalsrapport 2025-Q2 |
| 2025-06-13 | N/A | X-dag ordinarie utdelning INDCT 0.00 NOK |
| 2025-06-12 | N/A | Årsstämma |
| 2025-04-10 | - | Kvartalsrapport 2025-Q1 |
| 2025-02-13 | - | Bokslutskommuniké 2024 |
| 2024-11-14 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-15 | - | Kvartalsrapport 2024-Q2 |
| 2024-06-17 | - | X-dag ordinarie utdelning INDCT 0.00 NOK |
| 2024-06-14 | - | Årsstämma |
| 2024-05-16 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-15 | - | Bokslutskommuniké 2023 |
| 2023-11-15 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-17 | - | Kvartalsrapport 2023-Q2 |
| 2023-06-21 | - | Årsstämma |
| 2023-06-15 | - | X-dag ordinarie utdelning INDCT 0.00 NOK |
| 2023-05-16 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-15 | - | Bokslutskommuniké 2022 |
| 2022-11-15 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-17 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-12 | - | Kvartalsrapport 2022-Q1 |
| 2022-05-02 | - | X-dag ordinarie utdelning INDCT 0.00 NOK |
| 2022-02-15 | - | Bokslutskommuniké 2021 |
| 2021-11-01 | - | Kvartalsrapport 2021-Q3 |
| 2021-09-27 | - | Extra Bolagsstämma 2021 |
| 2021-08-16 | - | Kvartalsrapport 2021-Q2 |
| 2021-06-28 | - | Årsstämma |
| 2021-05-04 | - | X-dag ordinarie utdelning INDCT 0.00 NOK |
| 2021-05-03 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-16 | - | Bokslutskommuniké 2020 |
| 2020-10-30 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-14 | - | Kvartalsrapport 2020-Q2 |
| 2020-06-29 | - | Årsstämma |
| 2020-04-30 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-04 | - | X-dag ordinarie utdelning INDCT 0.00 NOK |
| 2020-02-03 | - | Bokslutskommuniké 2019 |
| 2019-10-31 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-15 | - | Kvartalsrapport 2019-Q2 |
| 2019-06-05 | - | X-dag ordinarie utdelning INDCT 0.00 NOK |
| 2019-04-30 | - | Kvartalsrapport 2019-Q1 |
| 2018-12-20 | - | Extra Bolagsstämma 2018 |
| 2018-04-13 | - | X-dag ordinarie utdelning INDCT 0.00 NOK |
| 2018-02-16 | - | Bokslutskommuniké 2017 |
| 2017-11-15 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-15 | - | Kvartalsrapport 2017-Q2 |
| 2017-05-16 | - | Kvartalsrapport 2017-Q1 |
| 2017-02-17 | - | Bokslutskommuniké 2016 |
| 2016-09-30 | - | Kvartalsrapport 2016-Q2 |
| 2016-05-31 | - | Bokslutskommuniké 2015 |
| 2016-04-18 | - | Extra Bolagsstämma 2016 |
Beskrivning
| Land | Norge |
|---|---|
| Lista | Euronext Growth Oslo |
| Sektor | Informationsteknik |
| Industri | Programvara |
2025-04-10 08:34:22
The Interim report for Q1 2025 for Induct AS has been approved by the Board of
Directors.
The results from the first quarter of 2025 show clear improvements in
profitability, and we have made significant strides toward becoming a more
efficient and scalable organization.
- EBITDA increased to NOK 3,0 in Q1 2025 from NOK 2,4 million in Q1 2024.
- Total operating costs reduced to NOK 1,9 million in Q1 2025 from NOK 3,1
million in Q1 2024.
- Gross margin on platform revenues at 96,8%.
- The Swedish version of Tilskuddsportalen, hittabidrag.se, was launched on 26
February with three subscription contracts already signed and a strong sales
pipeline consisting of individual municipalities and collaborative networks.
- Our collaboration with Portsmouth and AstraZeneca is progressing well and
according to plan. The hospital roll-out plan has been agreed, and Winchester
Hospital will be the first hospital to implement our asthma pathway product.
We are focused on and dedicated to increasing revenues to strengthen our EBITDA
further and deliver solid financial results.
For further information, please contact:
Synnøve Jacobsen
CEO
M: +47 99 41 54 47
E: sj@induct.net